1.
Rakesh Popat, Dana Warcel, Jenny O’Nions, Anna Cowley, Sasha Smith, William R Tucker, Kwee Yong, Simona Degli Esposti. Characterization of response and corneal events with extended follow-up after belantamab mafodotin (GSK2857916) monotherapy for patients with relapsed multiple myeloma: a case series from the first-time-in-human clinical trial. haematol [Internet]. 2020May1 [cited 2021Mar.8];105(5):e261-e263. Available from: https://haematologica.org/article/view/9416